The Axia Journal of Hematology and Oncology (AJHO) is a peer-reviewed, open-access journal dedicated to publishing high-quality research, clinical advancements, and innovative treatments in hematology and oncology. Our mission is to provide a platform for hematologists, oncologists, researchers, and healthcare professionals to share groundbreaking discoveries that improve the understanding, diagnosis, and treatment of blood disorders and cancers.
Scope:
- Hematologic Malignancies – Leukemia, lymphoma, multiple myeloma, and emerging targeted therapies.
- Solid Tumors – Breast cancer, lung cancer, colorectal cancer, prostate cancer, and rare malignancies.
- Molecular and Precision Oncology – Genomics, biomarker research, and personalized medicine approaches in cancer treatment.
- Immuno-Oncology and Cancer Immunotherapy – CAR-T cell therapy, checkpoint inhibitors, and immune response mechanisms.
- Stem Cell Transplantation and Cellular Therapy – Advances in bone marrow transplantation and stem cell-based therapies.
- Benign Hematology – Anemia, sickle cell disease, hemophilia, and thrombophilia.
- Coagulation Disorders and Thrombosis – Hemostasis, anticoagulation therapies, and venous thromboembolism management.
- Pediatric Hematology and Oncology – Childhood cancers, blood disorders, and pediatric treatment innovations.
- Hematopoiesis and Bone Marrow Disorders – Myelodysplastic syndromes, aplastic anemia, and bone marrow failure syndromes.
- Radiation Oncology – Innovations in radiotherapy techniques, proton therapy, and radiation toxicity management.
- Surgical Oncology – Advances in tumor resection, robotic surgery, and multidisciplinary cancer treatment.
- Palliative and Supportive Care in Oncology – Pain management, quality of life improvement, and end-of-life care.
- Oncologic Emergencies – Management of tumor lysis syndrome, spinal cord compression, and febrile neutropenia.
- Clinical Trials and Drug Development – Novel anti-cancer agents, phase I-III trials, and FDA-approved therapies.
- Cancer Epidemiology and Prevention – Risk factor identification, screening programs, and lifestyle interventions for cancer prevention.
AJHO serves hematologists, oncologists, radiation oncologists, medical researchers, pathologists, and healthcare professionals dedicated to advancing hematology and oncology research and clinical practice.
The journal follows a rigorous peer-review process, ensures international visibility through indexing in major scientific databases, and promotes rapid publication to disseminate high-impact research in hematology and oncology.